FDAJune 7, 2018drug

Maxzide-25 (Triamterene and hydrochlorothiazide) tablets, USP, 37.5 mg/ 25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-0464-01

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

Superpotent Drug: Composite assay results obtained during routine stability testing were slightly above specification.

What to do

FDA enforcement status: Terminated

Brands named

mylan pharmaceuticalsmylan

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →